Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners以買入評級開始對AcelRx Pharmicals進行報道,宣佈目標股價爲4.25美元
Alliance Global Partners analyst James Molloy initiates coverage on AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy rating and announces Price Target of $4.25.
Alliance Global Partners分析師詹姆斯·莫洛伊以買入評級啟動對AcelRx製藥(納斯達克:ACRX)的報道,並宣佈目標價為4.25美元。